| Today's Top Story |  |  | | - Obama administration wants ideas for National Bioeconomy Blueprint
The White House Office of Science and Technology Policy asked for input from the biomedical and biotech industries and research communities on its National Bioeconomy Blueprint. The initiative aims to identify strategies for meeting "grand challenges," focusing investments, boosting entrepreneurship and streamlining regulations. "Once unveiled, the National Bioeconomy Blueprint can leverage investments across the country in biotechnology research and development to create jobs and spur biological innovation on a grand scale," said Jim Greenwood, the CEO of BIO. GenomeWeb Daily News (10/17)        | Fly a lot? Earn 3X rewards points on airline purchases with The New Business Gold Rewards Card from American Express OPEN. Designed to earn Membership Rewards® points faster:
• 3X points on airfare
• 2X points on advertising, gas, and shipping
• 1X points on everything else
• Plus, 50K bonus points when you spend $10K your first 5 months
LEARN MORE AND APPLY |
  - Missing gene cluster may explain autism in humans
Researchers at the Cold Spring Harbor Laboratory in New York suggest that a 27-gene grouping on chromosome 16 may be missing in patients with autism and may play a role in the condition. Researchers found that mice without those genes developed hyperactivity. Examiner.com (10/18) - European Court upholds ban on some embryonic stem cell patents
The European Court of Justice ruled that processes are not patentable if they involve the destruction of a human embryo. The case involved a process invented by Oliver Bruestle of the University of Bonn for harvesting stem cells from blastocysts. Bruestle called the ruling "an unbelievable setback for biomedical stem cell research." Reuters (10/18)  | FREE TRIAL – Thomson Reuters Cortellis™ Pipeline Intelligence
Discover new opportunities in drug development and licensing faster. Cortellis gives you an innovative way of finding and acting on drug pipelines, deals, patents, companies, breaking industry news, and conference coverage in one source, intuitively presented.
Click here to see if you qualify for a free trial! |
 - Miragen and Servier form microRNA deal worth potentially $1B
Les Laboratoires Servier and Miragen Therapeutics agreed to jointly develop microRNA-based therapies for cardiovascular disease. Servier will pay as much as $45 million upfront for global marketing rights except in the U.S. and Japan to Miragen's two lead drug candidates. Servier has an option to commercialize a third product. The deal, which includes as much as $352 million in milestone fees to Miragen, might reach $1 billion if clinical support is factored in. Boulder County Business Report (Colo.) (10/18) - Marina Biotech gets investment pledge from Lincoln Park Capital Fund
Marina Biotech said in a regulatory filing that Lincoln Park Capital Fund plans to invest up to $15 million over the coming 30 months in the company. "This commitment by LPC provides additional financial flexibility as we continue our research and development efforts," said Michael French, CEO of Marina Biotech, which develops RNA interference drugs. Xconomy/Seattle (10/17) - Startup will bring gene sequencing to cancer care
Health care venture capitalist Brook Byers is partnering with Google Ventures in a Series A financing round worth $33.5 million to help establish Foundation Medicine. The startup will help physicians choose the right drug for cancer treatment using gene-sequencing technology. Novartis and Celgene are on board to use Foundation's test in trials. Marketing of the test, worth $3,500 to $4,500, to oncologists and pathologists could come next year. Forbes (10/18) - J&J turns facility into incubator for drug research startups
Johnson & Johnson on Tuesday announced it transformed part of its La Jolla, Calif., drug research center into an incubator to aid startup drug development and medical device companies. The arrangement will give small companies access to advanced research equipment and allow them to use their limited resources to move their products forward, said Diego Miralles, J&J's research center head. San Diego Union-Tribune (10/18)  | LET’S GO DESIGN: Episode #5
In this episode of SolidWorks’ interactive web series, Jeremy moves closer to the final design of our Hot Rod Baby Buggy and also hot-wires the golf cart motor to show how the aluminum tracks perform flawlessly. Watch at LetsGoDesign.tv. |
| Industrial & Environmental | |  | | |  | - USDA commits $15M for Southeast biomass-to-fuel initiative
The Department of Agriculture said it will allocate $15 million to establish the Southeast Partnership for Integrated Biomass Supply Systems, which would be tasked with developing a sustainable system for delivering feedstocks to advanced biofuel producers in the region. "One of the strengths and weaknesses of the region is that we have a very diverse landscape and sources of biomass," according to Tim Rials, who will lead the initiative. "What we're looking to do is take this to the next level, where we are optimally providing feedstock that is designed and tailored to different conversion technologies," Rials said. EthanolProducer.com (10/18)  | Enterprise Resource Planning automates many aspects of an organization's operations, cascading across traditional boundaries of operations, finance, manufacturing and more. As such, changes in the ERP market can cause a ripple effect in your business. Get ahead of the changing tide and trends by downloading this free whitepaper. |
 | News from BIO | | | | - Greater breadth of companies. Greater depth of knowledge.
The 10th Annual BIO Investor Forum, Oct. 25 and 26 in San Francisco, is a national investor forum exploring investment trends and opportunities in life sciences. Hear presentations from over 110 late-stage private and emerging public companies you won't see at other investor conferences. Meet one-on-one with new and current investors, analysts, and partnering companies. Gain insights from expert physicians, analysts, and company scientific officers at candid therapeutic and business panels. For program registration and more information, visit the BIO Investor Forum website.
| SmartQuote | | | |  | Some men have thousands of reasons why they cannot do what they want to, when all they need is one reason why they can."
--Willis R. Whitney,
American chemist  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Tuesday, October 18, 2011
- Monday, October 17, 2011
- Friday, October 14, 2011
- Thursday, October 13, 2011
- Wednesday, October 12, 2011
| | | Lead Editor: Adam Gaub
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | | | | | | © 1999-2011 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment